Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Drug Therapy | 2 |
| Pharmacology | 2 |
| Academic Ability | 1 |
| Adolescents | 1 |
| Behavior Change | 1 |
| Behavior Disorders | 1 |
| Behavior Patterns | 1 |
| Case Studies | 1 |
| Cognitive Ability | 1 |
| College Students | 1 |
| Correlation | 1 |
| More ▼ | |
Author
| Emslie, Graham J. | 1 |
| Inon, Magen | 1 |
| Kloos, Angelica | 1 |
| Kratochvil, Christopher J. | 1 |
| Waslick, Bruce | 1 |
| Weller, Elizabeth B. | 1 |
| Weller, Ronald A. | 1 |
Publication Type
| Journal Articles | 2 |
| Opinion Papers | 2 |
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkInon, Magen – Ethics and Education, 2019
Research shows that various pharmaceuticals can offer modest cognition enhancing effects for healthy individuals. These finding have caused some academics to support liberal use of pharmacological cognitive enhancement (PCE) in schools and universities. This approach partially arises from arguments implying there is little moral justification for…
Descriptors: Pharmacology, Drug Use, Cognitive Ability, Moral Values
Emslie, Graham J.; Waslick, Bruce; Weller, Elizabeth B.; Kloos, Angelica; Weller, Ronald A.; Kratochvil, Christopher J. – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
A 15-year-old male presents with moderately severe depression, and fluoxetine 20 mg is initiated. When he returns 14 days later, he describes suicidal ideations for the first time. He has recurrent thoughts of wishing he were dead, a plan, but no intent to act. How would this affect medication management? This article presents the opinions of five…
Descriptors: Suicide, Depression (Psychology), Males, Adolescents
